Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phCTGF (#RDB07807)

Promoter collection, Human CTGF promoter.

Alternative name U2927-12
Clone info. PCR amplified human CEBPA promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 33303920 to 33302423(NC_000019.10); relatively -1356 to +142, where +1 corresponds to 1 nt of NM_001285829.1.
Comment PCR cloning, forward primer:ccatgctctgaagcatcaac; reverse primer: actggctgtctcctctcagc. Entire sequence of insert has not been analyzed.Known difference: C to G substitution at 131,952,117.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human connective tissue growth factor genomic DNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07807 pGL4-phCTGF DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phCTGF was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07807).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07807_A6A8p1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: pGL4-4174F
Sequence file: RDB07807_A6A8a.seq check
>07807_07807_A6A8_pGL4-4174F_E02_14.ab1
    1 AAGGGGTCAG ACATTTCTCT GGCCTAACTG GCCGGTACCT GAGCTCGCTA GCCTCGAGGA
   61 TCCATGCTCT GAAGCATCAA CAACTTAAAG GAATCTACTC ATTGGTAACA CCAATGTCAA
  121 ATGATGCGGC ATTACAGAAT ACAAAAATGG TATGGCCCTA GAATCACTCT CTTTATATAA
  181 AATGGGAACT GGAGGTATTA ACAAAAAAGC CACTAAACAA CATAGATTCC AAATGAAAGC
  241 ACAGTGAATT AGTTGGGTCT TTAGTGAAGC TAAGTAGCAC TATATTAAGA AATGGAGATA
  301 TGCTTAGGTT TATTGGCCAT ATTCAACATC TGCACACACC CAGGGAGAAT AAAGCCTATT
  361 CTTTCCTTGT CCTGACCTCA CTCCCTCAGG CTGCATGTTC CTTGGGTAAT GAGAAGTCAC
  421 AATCACTATT CATAGATGTG TGGGGAGTCA CTAAAAATAT ATTATTCACT GTCAATCTTA
  481 GTTTATATCC AGATACAACA GGGTACACTG CTCTTGTAAT GGAATCAGAC TTCTTATTTT
  541 AACAAGACAA ACCAAATCCA ATCCACATTT GAAGATTATA GGTTTTAATA TAAGAAAATG
  601 CACTCATTTC TCAAAGACCC TAGTGAAGCT GTGTTTAAAT GCTCCTAGGT GAACCCCCTT
  661 TGCATCCCAG TGTTCCCACC CTGACACCCA GAGCCCCTAC CTACCCAACA CAGAATCATT
  721 TGCTCTGATA GAACAATGGA TCCCTTTTTC TGGAAACATT GATGGCCACT CGTCCCTTGT
  781 CCTTGCCTAT ATAAAACTCC TACATATATT AAGAGAAAAC TAAGCAAGAG TTTTGGAAAT
  841 CTGCCCCAGG AGACTGCATC CTGAGTCACA CGCGTCTTTG TTCTCTTTCT TGTCCCAAAA
  901 CCGTTACCTC AAGTGACAAA TGATCAAATC TCAAATATAG AATTCAGGTT TTACAGGTAG
  961 GCATCTTGAG GATTTCAAAT GGTTAAAAGC AACTCACTCC TTTTCTACTC TTTTGGAGAG
 1021 TTTCAGAGCC TATAGCCTCT AAAACGCAAA TCATTGCTAC GGTTGGGGGG GGGAGAAACC
 1081 TTTTCGACTT TTTAGAGTCT GCTGTTTGCC TCTCAGCTAC CTACTCCTAA ACGATGTTAT
1141 GTTCAGTGGA ACGAAACAGG CCAACCT
//
Primer: pGL4-136R
Sequence file: RDB07807_A6A8b.seq check
>07807_07807_A6A8_pGL4-136R_F02_17.ab1
    1 GGCCTAATGT TTTTGGCATC TTCATGGTGG CTTTACCAAC AGTACCGGAT TGCCAAGCTT
   61 GGCCGCCGAG GCCAGATCTT GATACTGGCT GTCTCCTCTC AGCGGGGAAG AGTTGTTGTG
  121 TGAGTTTGGG GCGGGCGGCC CGAGGCTTTT ATACGCTCCG GGCGGCCGCG GCTCGCCAAT
  181 GAGCTGAATG GAGTCCTACA CAAACAGGGA CATTCCTCGC ATTCCTCCCC ACCTTCCTGC
  241 CTCATCAACT CACACCGGAT TGATCCTGAC CCCTTGACAC TCAGCATTCC TCCGTCTGAA
  301 AAAGCTGGCA CACTCCAGCT CACAGAAAAA AAAAAAAGGA AAAAAAAAAG CGCAGTATTT
  361 CCAGCACCAA ATAGAATTTT TTTTTCCCTA TCCTCTTCGC ACCACTCCTG ATTCATATCA
  421 TTTATAAACA CACTGGCAAT TATTTCTTAT TTCTTTTTCG AATAAGTTTG CCCTGTTCTG
  481 TCCACTGACA TACATCCTTT TTAGGAAGTA GGTAGCTGAA GAGGCAAACA GCAGGAATTC
  541 CTAAAAAATT CGAAAAGGTT TCTCCCCCCC AACCCTTAGC AATGATTTGC GTTTTAGAGG
  601 CTATAGGCTC TTGAAACTCT CCAAAGAGTA GAAAAGGAGT GAGTTGCTTT TAACCATTTG
  661 AAATCCTCAA GATGCCTACC TGTAAAACCC TGAATTCTAT ATTTGAGATT TGATCATTTG
  721 TCACTTGAGG TAACGGTTTT GGGACAAGAA AGAGAACAAA GACGCGTGTG ACTCAGGATG
  781 CAGTCTCCTG GGGCAGATTT CCAAAACTCT TGCTTAGTTT TCTCTTAATA TATGTAGGAG
  841 TTTTATATAG GCAAGGACAA GGGACGAGTG GCCATCAATG TTTCCAGAAA AAGGGATCCA
  901 TTGTTCTATC AGAGCAAATG ATTCTGTGTT GGGTAGGTAG GGGCTCTGGG TGTCAGGTGG
  961 GAACACTGGG ATGCAAAGGG GGTTCACCTA GGAGCATTTA ACACAGCTTC ACTAGGTCTT
 1021 TGAGAAATGA GTGCATTTTT CTTATATAAA CTATATCTCA ATGTGGATGG ATTGCATTTG
 1081 TCTGTAAATA GAGTCTGATT CCATTACAAG AGCATTGTAA CCTGCTGAAT CTGCAATTAT
1141 AAACTTAAGG AT
//
Primer: pAxCALNL_F1
Sequence file: RDB07807_A6A8c.seq check
>07807_07807_A6A8_pAxCALNL_F1_G02_20.ab1
    1 ACAAATCTAT CTTATCATGT CTGCTCGAAG CGGCCGGCCG CCCCGACTCT AGAATTATTA
   61 CACGGCGATC TTGCCGCCCT TCTTGGCCTT AATGAGAATC TTGCGGATCT TGCGGGCGTC
  121 CAACTTGCCG GTCAGTCCTT TAGGCACCTC GTCCACGAAC ACAACACCAC CGCGCAGCTT
  181 CTTGGCGGTT GTAACCTGGC TGGCCACATA GTCCACGATC TCCTTCTCGG TCATGGTTTT
  241 ACCGTGTTCC AGCACGACGA CTGCGGCGGG CAGCTCGCCG GCATCGTCGT CGGGCAGGCC
  301 GGCGACCCCG GCGTCGAAGA TGTTGGGGTG TTGCAGCAGG ATGCTCTCCA GTTCGGCTGG
  361 GGCTACCTGG TAGCCCTTGT ATTTGATCAG GCTCTTCAGC CGGTCCACGA TGAAGAAGTG
  421 CTCGTCCTCG TCCCAGTAGG CGATGTCGCC GCTGTGCAGC CAGCCGTCCT TGTCGATGAG
  481 AGCGTTTGTA GCCTCGGGGT TGTTAACGTA GCCGCTCATG ATCATGGGGC CACGGACGCA
  541 CAGCTCGCCG CGCTGGTTCA CACCCAGTGT CTTACCGGTG TCCAAGTCCA CCACCTTAGC
  601 CTCGAAGAAG GGCACCACCT TGCCTACTGC GCCAGGCTTG TCGTCCCCTT CGGGGGTGAT
  661 CAGAATGGCG CTGGTTGTTT CTGTCAGGCC GTAGCCCTGG CGGATGCCTG GTAGGTGGAA
  721 GCGTTTGGCC ACGGCCTCAC CTACCTCCTT GCTGAGCGGC GCCCCGCCGC TGGCGATCTC
  781 GTGCAAGTTG CTTAGGTCGT ACTTGTCGAT GAGAGTGCTC TTAGCGAAGA AGCTAAATAG
  841 TGTGGGCACC AGCAGGGCAG ATTGAATCTT ATAGTCTTGC AAGCTGCGCA AGAATAGCTC
  901 CTCCTCGAAG CGGTACATGA GCACGACCCG AAAGCCGCAG ATCAAGTAGC CCAGCGTGGT
  961 GAACATGCCG AAGCCGTGGT GAAATGGCAC CACGCTGAGG ATAGCGGTGT CGGGGATGAT
 1021 CTGGTTGCCG AGATGGGGTC GCGGGCATGA CTGAATCGGA CACAAGCGGT GCGGTGCGTA
 1081 GCTACGCCCT GGGCAATCCG TACTGCACTA CTGATCATGA ATCAAGCGAT GGATTTTGTT
1141 CCGGATCGGA AGTC
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles